Skip to main content
Erschienen in: Die Ophthalmologie 3/2023

24.01.2023 | Diabetische Retinopathie | Leitlinien, Stellungnahmen und Empfehlungen

Pseudophakes zystoides Makulaödem

Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands. Stand 22.10.2022

verfasst von: Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e. V. (RG), Berufsverband der Augenärzte Deutschlands e. V. (BVA)

Erschienen in: Die Ophthalmologie | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Auszug

Das pseudophake zystoide Makulaödem (PZMÖ) gehört mit einem Risiko von 1,2 % zu den häufigsten visusmindernden Komplikationen nach Kataraktoperation. …
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bertelmann T, Witteborn M, Mennel S (2012) Das pseudophakiebedingte zystoide Makulaodem. Klin Monbl Augenheilkd 229:798–811CrossRefPubMed Bertelmann T, Witteborn M, Mennel S (2012) Das pseudophakiebedingte zystoide Makulaodem. Klin Monbl Augenheilkd 229:798–811CrossRefPubMed
2.
Zurück zum Zitat Guo S, Patel S, Baumrind B et al (2015) Management of pseudophakic cystoid macular edema. Surv Ophthalmol 60:123–137CrossRefPubMed Guo S, Patel S, Baumrind B et al (2015) Management of pseudophakic cystoid macular edema. Surv Ophthalmol 60:123–137CrossRefPubMed
3.
Zurück zum Zitat Han JV, Patel DV, Squirrell D et al (2019) Cystoid macular oedema following cataract surgery: a review. Clin Exp Ophthalmol 47:346–356CrossRefPubMed Han JV, Patel DV, Squirrell D et al (2019) Cystoid macular oedema following cataract surgery: a review. Clin Exp Ophthalmol 47:346–356CrossRefPubMed
4.
Zurück zum Zitat Radeck V, Marker D, Prahs P et al (2020) Pseudophakes zystoides Makulaödem. Ophthalmologe 117:579–590CrossRefPubMed Radeck V, Marker D, Prahs P et al (2020) Pseudophakes zystoides Makulaödem. Ophthalmologe 117:579–590CrossRefPubMed
5.
Zurück zum Zitat Gass JD, Norton EW (1966) Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol 76:646–661CrossRefPubMed Gass JD, Norton EW (1966) Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol 76:646–661CrossRefPubMed
6.
Zurück zum Zitat Chu CJ, Johnston RL, Buscombe C et al (2016) Risk factors and incidence of macular edema after cataract surgery: a database study of 81984 eyes. Ophthalmology 123:316–323CrossRefPubMed Chu CJ, Johnston RL, Buscombe C et al (2016) Risk factors and incidence of macular edema after cataract surgery: a database study of 81984 eyes. Ophthalmology 123:316–323CrossRefPubMed
7.
Zurück zum Zitat Tu KL, Kaye SB, Sidaras G et al (2007) Effect of intraocular surgery and ketamine on aqueous and serum cytokines. Mol Vis 13:1130–1137PubMedPubMedCentral Tu KL, Kaye SB, Sidaras G et al (2007) Effect of intraocular surgery and ketamine on aqueous and serum cytokines. Mol Vis 13:1130–1137PubMedPubMedCentral
8.
Zurück zum Zitat Chung YR, Kim YH, Lee SY et al (2019) Insights into the pathogenesis of cystoid macular edema: leukostasis and related cytokines. Int J Ophthalmol 12:1202–1208CrossRefPubMedPubMedCentral Chung YR, Kim YH, Lee SY et al (2019) Insights into the pathogenesis of cystoid macular edema: leukostasis and related cytokines. Int J Ophthalmol 12:1202–1208CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat McCafferty S, Harris A, Kew C et al (2017) Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3 % versus placebo. BMC Ophthalmol 17:16CrossRefPubMedPubMedCentral McCafferty S, Harris A, Kew C et al (2017) Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3 % versus placebo. BMC Ophthalmol 17:16CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Hollo G, Aung T, Cantor LB et al (2020) Cystoid macular edema related to cataract surgery and topical prostaglandin analogs: mechanism, diagnosis, and management. Surv Ophthalmol 65:496–512CrossRefPubMed Hollo G, Aung T, Cantor LB et al (2020) Cystoid macular edema related to cataract surgery and topical prostaglandin analogs: mechanism, diagnosis, and management. Surv Ophthalmol 65:496–512CrossRefPubMed
11.
Zurück zum Zitat Miyake K, Ota I, Ibaraki N et al (2001) Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol 119:387–394CrossRefPubMed Miyake K, Ota I, Ibaraki N et al (2001) Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol 119:387–394CrossRefPubMed
12.
Zurück zum Zitat Taipale C, Holmstrom EJ, Ilveskoski L et al (2019) Incidence of pseudophakic cystoid macular edema in eyes with and without pupil expansion device. Acta Ophthalmol 97:688–694CrossRefPubMed Taipale C, Holmstrom EJ, Ilveskoski L et al (2019) Incidence of pseudophakic cystoid macular edema in eyes with and without pupil expansion device. Acta Ophthalmol 97:688–694CrossRefPubMed
13.
Zurück zum Zitat Blouin MC, Blouin J, Perreault S et al (2007) Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin. J Cataract Refract Surg 33:1227–1234CrossRefPubMed Blouin MC, Blouin J, Perreault S et al (2007) Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin. J Cataract Refract Surg 33:1227–1234CrossRefPubMed
14.
Zurück zum Zitat Bradford JD, Wilkinson CP, Bradford RH Jr. (1988) Cystoid macular edema following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Retina 8:161–164CrossRefPubMed Bradford JD, Wilkinson CP, Bradford RH Jr. (1988) Cystoid macular edema following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Retina 8:161–164CrossRefPubMed
15.
Zurück zum Zitat Hunter AA, Modjtahedi SP, Long K et al (2014) Improving visual outcomes by preserving outer retina morphology in eyes with resolved pseudophakic cystoid macular edema. J Cataract Refract Surg 40:626–631CrossRefPubMed Hunter AA, Modjtahedi SP, Long K et al (2014) Improving visual outcomes by preserving outer retina morphology in eyes with resolved pseudophakic cystoid macular edema. J Cataract Refract Surg 40:626–631CrossRefPubMed
16.
Zurück zum Zitat Kessel L, Tendal B, Jorgensen KJ et al (2014) Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology 121:1915–1924CrossRefPubMed Kessel L, Tendal B, Jorgensen KJ et al (2014) Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology 121:1915–1924CrossRefPubMed
17.
Zurück zum Zitat Lim BX, Lim CH, Lim DK et al (2016) Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery. Cochrane Database Syst Rev 11:CD6683PubMed Lim BX, Lim CH, Lim DK et al (2016) Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery. Cochrane Database Syst Rev 11:CD6683PubMed
18.
Zurück zum Zitat Wielders LH, Lambermont VA, Schouten JS et al (2015) Prevention of cystoid macular edema after cataract surgery in nondiabetic and diabetic patients: a systematic review and meta-analysis. Am J Ophthalmol 160:968–981.e33CrossRefPubMed Wielders LH, Lambermont VA, Schouten JS et al (2015) Prevention of cystoid macular edema after cataract surgery in nondiabetic and diabetic patients: a systematic review and meta-analysis. Am J Ophthalmol 160:968–981.e33CrossRefPubMed
19.
Zurück zum Zitat Wielders LHP, Schouten J, Winkens B et al (2018) European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1. J Cataract Refract Surg 44:429–439CrossRefPubMed Wielders LHP, Schouten J, Winkens B et al (2018) European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1. J Cataract Refract Surg 44:429–439CrossRefPubMed
20.
Zurück zum Zitat Donnenfeld ED, Perry HD, Wittpenn JR et al (2006) Preoperative ketorolac tromethamine 0.4 % in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg 32:1474–1482CrossRefPubMed Donnenfeld ED, Perry HD, Wittpenn JR et al (2006) Preoperative ketorolac tromethamine 0.4 % in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg 32:1474–1482CrossRefPubMed
21.
Zurück zum Zitat Yavas GF, Ozturk F, Kusbeci T (2007) Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. J Cataract Refract Surg 33:804–807CrossRefPubMed Yavas GF, Ozturk F, Kusbeci T (2007) Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. J Cataract Refract Surg 33:804–807CrossRefPubMed
22.
23.
Zurück zum Zitat Guidera AC, Luchs JI, Udell IJ (2001) Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology 108:936–944CrossRefPubMed Guidera AC, Luchs JI, Udell IJ (2001) Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology 108:936–944CrossRefPubMed
24.
Zurück zum Zitat Miller KM, Oetting TA, Tweeten JP et al (2022) Cataract in the adult eye preferred practice pattern. Ophthalmology 129:P1–P126CrossRefPubMed Miller KM, Oetting TA, Tweeten JP et al (2022) Cataract in the adult eye preferred practice pattern. Ophthalmology 129:P1–P126CrossRefPubMed
26.
Zurück zum Zitat Wielders LHP, Schouten J, Winkens B et al (2018) Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED study report 2. J Cataract Refract Surg 44:836–847CrossRefPubMed Wielders LHP, Schouten J, Winkens B et al (2018) Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED study report 2. J Cataract Refract Surg 44:836–847CrossRefPubMed
27.
Zurück zum Zitat Schilling H, Pauleikhoff D, Schrenk M et al (1993) Therapie zystoider und diffuser Makulaodeme nach Uveitis und Katarakt-Chirurgie mit dem Carboanhydrase-Hemmer Acetazolamid (Diamox). Klin Monbl Augenheilkd 202:206–211CrossRefPubMed Schilling H, Pauleikhoff D, Schrenk M et al (1993) Therapie zystoider und diffuser Makulaodeme nach Uveitis und Katarakt-Chirurgie mit dem Carboanhydrase-Hemmer Acetazolamid (Diamox). Klin Monbl Augenheilkd 202:206–211CrossRefPubMed
28.
Zurück zum Zitat Pepple KL, Nguyen MH, Pakzad-Vaezi K et al (2019) Response of inflammatory cystoid macular edema to treatment using oral acetazolamide. Retina 39:948–955CrossRefPubMedPubMedCentral Pepple KL, Nguyen MH, Pakzad-Vaezi K et al (2019) Response of inflammatory cystoid macular edema to treatment using oral acetazolamide. Retina 39:948–955CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Kuley B, Storey PP, Wibbelsman TD et al (2021) Resolution of pseudophakic cystoid macular edema: 2 mg Intravitreal triamcinolone acetonide versus 40 mg posterior sub-tenon triamcinolone acetonide. Curr Eye Res 46:824–830CrossRefPubMed Kuley B, Storey PP, Wibbelsman TD et al (2021) Resolution of pseudophakic cystoid macular edema: 2 mg Intravitreal triamcinolone acetonide versus 40 mg posterior sub-tenon triamcinolone acetonide. Curr Eye Res 46:824–830CrossRefPubMed
31.
Zurück zum Zitat Tariq F, Wang Y, Ma B et al (2022) Efficacy of intravitreal injection of filtered modified low-dose triamcinolone acetonide and ranibizumab on pseudophakic cystoid macular edema. Front Med (Lausanne) 9:777549CrossRefPubMedPubMedCentral Tariq F, Wang Y, Ma B et al (2022) Efficacy of intravitreal injection of filtered modified low-dose triamcinolone acetonide and ranibizumab on pseudophakic cystoid macular edema. Front Med (Lausanne) 9:777549CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Bellocq D, Pierre-Kahn V, Matonti F et al (2017) Effectiveness and safety of dexamethasone implants for postsurgical macular oedema including Irvine-Gass syndrome: the EPISODIC-2 study. Br J Ophthalmol 101:333–341PubMed Bellocq D, Pierre-Kahn V, Matonti F et al (2017) Effectiveness and safety of dexamethasone implants for postsurgical macular oedema including Irvine-Gass syndrome: the EPISODIC-2 study. Br J Ophthalmol 101:333–341PubMed
33.
Zurück zum Zitat Spitzer MS, Ziemssen F, Yoeruek E et al (2008) Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. J Cataract Refract Surg 34:70–75CrossRefPubMed Spitzer MS, Ziemssen F, Yoeruek E et al (2008) Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. J Cataract Refract Surg 34:70–75CrossRefPubMed
34.
Zurück zum Zitat Staurenghi G, Lai TYY, Mitchell P et al (2018) Efficacy and safety of ranibizumab 0.5 mg for the treatment of macular edema resulting from uncommon causes: twelve-month findings from PROMETHEUS. Ophthalmology 125:850–862CrossRefPubMed Staurenghi G, Lai TYY, Mitchell P et al (2018) Efficacy and safety of ranibizumab 0.5 mg for the treatment of macular edema resulting from uncommon causes: twelve-month findings from PROMETHEUS. Ophthalmology 125:850–862CrossRefPubMed
Metadaten
Titel
Pseudophakes zystoides Makulaödem
Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands. Stand 22.10.2022
verfasst von
Deutsche Ophthalmologische Gesellschaft (DOG)
Retinologische Gesellschaft e. V. (RG)
Berufsverband der Augenärzte Deutschlands e. V. (BVA)
Publikationsdatum
24.01.2023
Verlag
Springer Medizin
Erschienen in
Die Ophthalmologie / Ausgabe 3/2023
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI
https://doi.org/10.1007/s00347-022-01771-8

Weitere Artikel der Ausgabe 3/2023

Die Ophthalmologie 3/2023 Zur Ausgabe

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.